Vnitr Lek 2009, 55(9):774-778

Liver cirrhosis and its treatment

J. Lata*, T. Vaňásek, O. Stibůrek
Interní hepatogastroenterologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jan Lata, CSc.

Cirrhosis is an end-stage liver disease. It is necessary to always search for the cause, attempt to initiate suitable causal treatment and assess the severity of hepatopathy by evaluating hepatic functional reserve (according to the Child-Pugh classification). It is necessary to continually monitor possible complications of cirrhosis, some can be prevented. Regular clinical and laboratory monitoring as well as ultrasound and endoscopic examinations are required. The paper discusses the treatment of the disease as well as its complications. Cure can only be achieved with a liver transplant; this option should be evaluated by a hepatologist in each patient with functional classification B or with serious complications of portal hypertension mentioned above. Treatment standards compiled by the Czech Society of Hepatology (http://www.ceska-hepatologie.cz) offer the basic algorithms of correct diagnosis and treatment.

Keywords: liver cirrhosis; portal hypertension; bleeding oesophageal varices; ascites; spontaneous bacterial peritonitis; hepatorenal syndrome; hepatocellular carcinoma

Received: July 16, 2009; Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lata J, Vaňásek T, Stibůrek O. Liver cirrhosis and its treatment. Vnitr Lek. 2009;55(9):774-778.
Download citation

References

  1. Sherlocková S, Dooley J. Nemoci jater a žlučových cest. 11. vyd. Hradec Králové: Olga Čermáková publishing 2004.
  2. Brůha R, Drastich P, Hůlek P et al. Diagnostika a léčba jaterní encefalopatie. Vnitř Lék 2006; 52: 85-86. Go to PubMed...
  3. Parés A, Caballería I, Rodés J et al. Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial. UDCA-Cooperative Group from the Spanish Association for the Study of the Liver. J Hepatol 2000; 32: 561-566. Go to original source... Go to PubMed...
  4. Jacobs BP, Dennehy C, Ramirez G et al. Milk thistle for the treatment of liver diseases: a systematic review and meta-analysis. Am J Med 2002; 113: 506-515. Go to original source... Go to PubMed...
  5. Brůha R, Mareček Z. Esenciální fosfolipidy v léčbě jaterní encefalopatie. Vnitř Lék 2000; 46: 199-204. Go to PubMed...
  6. Lata J, Kroupa R, Novotný I et al. Akutní krvácení z horní části gastrointestinálního traktu. Vnitř Lék 2009; 55 (Suppl 1): S29-S33.
  7. Imazu H, Seewald S, Omar S et al. Endoscopic Treatment for Portal Hypertension: What's New in the Last 12 Months? Endoscopy 2005; 37: 116-121. Go to original source... Go to PubMed...
  8. Møller S, Henriksen JH, Bendtsen F. Ascites: Pathogenesis and therapeutic principles. Scand J Gastroenterol 2009; 8: 902-911. Go to original source... Go to PubMed...
  9. Khan J, Pikkarainen P, Karvonen AL et al. Ascites: Aetiology, mortality and the prevalence of spontaneous bacterial peritonitis. Scand J Gastroenterol 2009; 8: 970-974. Go to original source... Go to PubMed...
  10. Brůha R, Balihar K, Drastich P et al. Doporučený postup pro diagnostiku a léčbu hepatorenálního syndromu. Vnitř Lék 2006; 52: 649-650. Go to PubMed...
  11. Rougier P, Mitry E, Barbare JC et al. Hepatocellular carcinoma (HCC): an update. Semin Oncol 2007; 34 (2 Suppl 1): S12-S20. Go to original source... Go to PubMed...
  12. Rodríguez-Roisin R, Krowka MJ. Hepatopulmonary Syndrome - A Liver-Induced Lung Vascular Disorder. N Engl J Med 2008; 358: 2378-2387. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.